About Edaravone
Class: | Neuroprotective agent
Use: | Treatment of amyotrophic lateral sclerosis (ALS) and acute ischemic stroke
Adult dose: | 60 mg administered as a continuous intravenous infusion over 60 minutes, followed by 30 mg administered as a continuous infusion over 60 minutes for 14 days, then a 14-day drug-free period
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children
Side effects: | Common side effects include bruising, gait dist
Drug Class
Neuroprotective agent
Uses & Indications
Treatment of amyotrophic lateral sclerosis (ALS) and acute ischemic stroke
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from light; do not freeze
Manufacturer & Packaging
Manufacturer: NICHE-IKO, JAPAN
Package Size
Premixed Infusion x 10s
Price & Supplier
Price in UAE: AED 4025.00
Dosage Information
Adult Dose
60 mg administered as a continuous intravenous infusion over 60 minutes, followed by 30 mg administered as a continuous infusion over 60 minutes for 14 days, then a 14-day drug-free period
Pediatric Dose
Safety and efficacy not established in pediatric patients; not recommended for use in children
Side Effects
Common side effects include bruising, gait disturbance, headache, and liver enzyme elevations
Contraindications & Precautions
Hypersensitivity to edaravone or any component of the formulation; caution in patients with renal impairment
Important Warnings
Risk of serious allergic reactions; monitor for signs of hypersensitivity; use with caution in patients with a history of asthma or allergic reactions
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.